Results 271 to 280 of about 332,173 (306)
Some of the next articles are maybe not open access.

Cardiac Biomarkers in Emergency Care

Cardiology Clinics, 2018
This article critically reviews the latest evidence to guide the use of biomarkers for the diagnosis of acute coronary syndromes in practice. It shows how modern cardiac troponin assays can enable diagnoses to be ruled in or ruled out with a single blood test, with many more diagnoses confirmed or refuted in as little as 1 hour later.
Body, Richard, Hendry, Cara
openaire   +2 more sources

Cardiac Biomarkers

2023
Aldo Clerico, Martina Zaninotto
openaire   +2 more sources

Cardiac biomarkers in neonatal hypoxic ischaemia

Acta Paediatrica, 2011
AbstractFollowing a perinatal hypoxic–ischaemic insult, term infants commonly develop cardiovascular dysfunction. Troponin‐T, troponin‐I and brain natriuretic peptide are sensitive indicators of myocardial compromise. The long‐term effects of cardiovascular dysfunction on neurodevelopmental outcome following perinatal hypoxic ischaemia remain ...
Sweetman, D   +3 more
openaire   +3 more sources

Using Cardiac Biomarkers in Veterinary Practice

Veterinary Clinics of North America: Small Animal Practice, 2013
Blood-based assays for various cardiac biomarkers can assist in the diagnosis of heart disease in dogs and cats. The two most common markers are cardiac troponin-I and N-terminal pro-B-type natriuretic peptide. Biomarker assays can assist in differentiating cardiac from noncardiac causes of respiratory signs and detection of preclinical cardiomyopathy.
openaire   +3 more sources

Cardiac biomarkers: a review

Comparative Clinical Pathology, 2003
Cardiac injury can develop secondary to compromise due to disease or drug toxicity, among other causes. The clinical signs of cardiac problems can be confused with those of other conditions, such as respiratory disease. Therefore, specific, sensitive, rapid and inexpensive blood tests for cardiac injury are desirable.
openaire   +1 more source

Cardiac biomarkers

American Journal of Critical Care, 1999
GR Pesola, HR Pesola, DA Pesola
openaire   +1 more source

Biomarkers in Subclinical Transthyretin Cardiac Amyloidosis

Current Heart Failure Reports
The most common type of cardiac amyloidosis is transthyretin amyloidosis (ATTR-CM). Early forms of the disease can often go undetected. Effective pharmacological treatments are available for ATTR-CM. However, current treatment options may be more effective when used earlier in the disease, making early detection paramount.
Jaskeerat S, Gulati   +6 more
openaire   +2 more sources

Cardiac Biomarkers

2006
R Wright, Dariush Takhtehchian
openaire   +1 more source

Cardiac Biomarkers

2014
Y. Xue   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy